Wuhan General Group, Inc. announced that Dr. Hyder A. Khoja is joining Wuhan General Group as Chief Scientific Officer. In his role as CSO, Dr. Khoja will oversee the company’s core research and product development to commercialization. Dr. Khoja is a trusted and distinguished global leader in cannabinoid & psychedelic medicine. He possesses comprehensive knowledge of the pharmaceutical and dietary supplements industries. His extensive industrial experience spans from advising, innovating and developing cutting-edge projects, to holding various senior-level executive and senior research positions at various biotech companies, universities, and research institutes. His expertise in science and policy domains have led to a distinguished career in scientific research and business development. Dr. Khoja is excited to apply his extensive knowledge with Wuhan to advance botanical-based medicine within the realm of cannabis and mushrooms.